Visit Cantabio Pharmaceuticals

Developer of biotechnological therapies and intellectual property. The company focuses on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson?s disease, Alzheimer?s disease and other related neurodegenerative diseases. Its strategy integrates a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach, which is currently identifying and developing small molecule pharmacological chaperones for clinical trials. In addition, the company is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins which display loss of function during disease conditions.